Tesamorelin
Also known as: Egrifta
Growth hormone-releasing hormone (GHRH) analog
Mechanism of Action
Stimulates pituitary release of growth hormone, reducing visceral adipose tissue.
Reported Outcomes
Clinical Strength: C (19 trials)Based on community reports (365 posts). Grade reflects frequency and consistency of positive mentions.
Changes in muscle vs fat ratio
Reduction in body weight
Effects on sleep quality
Reduced hunger and food cravings
Changes in energy and fatigue levels
Effects on mood and cognitive function
Improved glycemic control and insulin sensitivity
Effects on heart health markers
Side Effects
Based on 71 user reports. Frequency indicates how often each was mentioned.
Common (>5%)
Uncommon (1-5%)
Risks & Warnings
Important safety considerations based on clinical data and community reports.
Muscle Loss
Rapid weight loss may include muscle. Adequate protein intake and resistance training recommended.
Injection Site Reactions
Local reactions are common and usually mild. Rotate injection sites.
Gastrointestinal Issues
GI side effects are the most commonly reported. Usually improve over time with slow titration.
Dosing
Standard Protocol
- Starting Dose
- 2mg daily
- Titration
- Fixed dose
- Half-life
- 26-38 minutes
- Administration
- Subcutaneous injection, once daily
Community Dosing Patterns
Based on 97 mentions
Community-reported patterns, not medical advice.
Pricing
Research-grade reference pricing for 10mg vial. Prices vary by vendor and quantity.
We do not list vendors. Prices are aggregated from community reports and should be treated as rough ranges.
US Research Grade
Single small vial from US domestic vendors
US Research Grade (Bulk)
Per-dose equivalent when buying larger US vials
China Research Grade
Per-vial when buying 10-pack from Chinese vendors
74% savings
Research
Key Studies
PLoS One (2024)
Anal Sci Adv (2022)
Top Antivir Med (2024)
AIDS (London, England) (2024)
Cureus (2025)
Commonly Stacked With
Based on 365 community posts mentioning Tesamorelin.
Switching Patterns
Based on 30 discussions about switching to or from Tesamorelin.
→ Switching FROM
Users who switched to Tesamorelin
← Switching TO
Users who switched from Tesamorelin